[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355890-105":59,"doc-detail-355890-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","evaluation-of-prostate-cancer-diagnosis-during-the-covid-19-crisis-in-the-french-caribbean","Evaluation of prostate cancer diagnosis during the COVID-19 crisis in the French Caribbean","","Prostate cancer incidence differs markedly by region, and the COVID-19 pandemic disrupted diagnostic activities, potentially altering cancer outcomes. This study compares incidence, patient characteristics, and survival among individuals with invasive prostate adenocarcinoma diagnosed in Martinique before versus during COVID-19 (2015–2022) using the Martinique Cancer Registry. Incidence declined by 18% after the pandemic onset and then rose annually; overall survival was lower for COVID-19–period diagnoses.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evaluation-of-prostate-cancer-diagnosis-during-the-covid-19-crisis-in-the-french-caribbean/355890/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evaluation-of-prostate-cancer-diagnosis-during-the-covid-19-crisis-in-the-french-caribbean/355890.png","ImageObject",300,407,{"name":92,"@type":93},"Elsa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",25,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main objective of the study in Martinique?","Question",{"text":113,"@type":114},"To compare prostate cancer incidence, demographic and clinical profiles, and patient survival between periods before and during the COVID-19 pandemic.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which patients and time range were included?",{"text":118,"@type":114},"Patients diagnosed with invasive prostate adenocarcinoma in Martinique between January 1, 2015 and December 31, 2022 were included using the Martinique Cancer Registry.",{"name":120,"@type":111,"acceptedAnswer":121},"How did COVID-19 affect incidence and survival outcomes?",{"text":122,"@type":114},"Incidence decreased by 18% after the pandemic onset and then increased on average each year; overall survival was lower among patients diagnosed during the COVID-19 period.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355890,1790183470,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":46,"preview_page_count":19,"preview_urls":145},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nEvaluation of prostate cancer diagnosis during the COVID-19 crisis in the French Caribbean  \nMurielle Beaubrun-Renard1,2􀀍, Stephen Ulric-Gervaise1, Jonathan Macni1, Adrian Puello1,3, André Cabie2,4,5 & Clarisse Joachim1,3  \nProstate cancer incidence varies considerably across regions worldwide. In Martinique, the incidence reached 164, 5 per 100,000 person-years between 2008 and 2014, ranking among the highest globally. During the COVID-19 pandemic, diagnostic activities were severely disrupted, which may have impacted prostate cancer outcomes. This study aimed to compare incidence, characteristics, and survival of prostate cancer patients diagnosed in Martinique before and during the COVID-19 pandemic. This study included patients diagnosed with invasive prostate adenocarcinoma between January 1, 2015, and December 31, 2022, from the Martinique Cancer Registry database. Patients were characterized according to the diagnosis period (pre-COVID vs. COVID). Variations in incidence were analysed using Poisson model. A log-rank test was used to compare survival curve. Multivariable Cox model were applied to identify factors for survival. A total of 4824 patients were included, with a mean age of 67.4 years (± 9.0). The incidence rate decreased by 18% after the onset of the pandemic (p = 0.006), followed by an average annual increase of 7%(p = 0.03). Overall survival was lower among patients diagnosed during the COVID-19 period (p = 0.007). The COVID-19 pandemic affected prostate cancer screening and diagnostic pathways as well as disease prognosis. Extended follow-up is required to assess the long-term impact on stage at diagnosis and patient outcomes.  \nKeywords Prostate cancer, Incidence, Survival, COVID-19, French Caribbean, Martinique  \nThe COVID-19 pandemic has disrupted cancer care globally, and in regions with exceptionally high prostate cancer incidence, such as Martinique, its impact on diagnosis and survival warrants urgent investigation. Prostate cancer is a major public health issue and the most common solid tumor in France. In 2018, its incidence was estimated at 59,885 new cases in mainland France, corresponding to a world-standardized rate of 89.9 cases per 100,000 person-years1. Prognosis is generally favourable, with a 5-year survival exceeding 90%, as 80% of cases are diagnosed at a localized stage2. However, when diagnosed at a metastatic stage, the 5-year survival probability decreases to 50%3. In Martinique, in addition to genetic predisposition, environmental exposure such as the use of Chlordecone, a recognized carcinogen, has been shown to amplify the risk of prostate cancer4,5. With a world-standardized incidence of 164.5 per 100,0006, prostate cancer is markedly more frequent in Martinique compared to mainland France and other Caribbean countries7–9. Between 2008 and 2015, incidence rates declined in certain regions of the United States, including New York and Pennsylvania (annual percent change in incidence: − 5.2 [− 6.4 to − 3.9] and − 5.8 [− 8.3 to − 3.3], respectively). In contrast, during the same period, incidence rates in Martinique remained stable10.  \nThe COVID-19 pandemic, declared in 2020, led to unprecedented public health measures worldwide. In France, a national lockdown was implemented on March 16th, 2020, in response to the rapid spread of the virus and rising mortality. Beyond its direct health impact, the pandemic and associated restrictions had major psychological and organizational consequences, disrupting healthcare systems and continuity of care. Fear of infection and restricted access to medical facilities contributed to delays in diagnosis and interruptions in preventive services, including cancer screening programs11, 12.  \n1Centre Hospitalier Universitaire de Martinique, Pôle de Cancérologie HématologieUrologie, UF 1441 Registre Général des cancers de la Martinique, 97200 Martinique, France. 2PCCEI, In","cbCaifdPXI0eFJVq","https://ap.wps.com/l/cbCaifdPXI0eFJVq","pdf",1504966,"English","# Materials and methods\n## Study population\n## Variables","[{\"question\":\"What was the main objective of the study in Martinique?\",\"answer\":\"To compare prostate cancer incidence, demographic and clinical profiles, and patient survival between periods before and during the COVID-19 pandemic.\"},{\"question\":\"Which patients and time range were included?\",\"answer\":\"Patients diagnosed with invasive prostate adenocarcinoma in Martinique between January 1, 2015 and December 31, 2022 were included using the Martinique Cancer Registry.\"},{\"question\":\"How did COVID-19 affect incidence and survival outcomes?\",\"answer\":\"Incidence decreased by 18% after the pandemic onset and then increased on average each year; overall survival was lower among patients diagnosed during the COVID-19 period.\"}]","Evaluation of prostate cancer diagnosis during the COVID-19 crisis in the French Caribbean | PDF",1790121566,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f55ee82560a42611ee97c18e550b732e.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/518abb42bbcfa85a0283dedaee3ca445.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/160b60b1a687e2d9c030090e6820cf74.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3a7ede671a8dfad34fe97a08468dc3b.webp",980,1287]